Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Incidental Small Cell Lung Cancer After Radical Resection of Lung Cancer: A Single-Center, Randomized Controlled Clinical Study Protocol Number: LungMate-033

Clinical trial NCT07097948 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07097948
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Postoperative Incidental Small Cell Lung Cancer Toripalimab Adjuvant Therapy Evaluation

Start date: 2025-08-01
Primary completion: 2030-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.